No Data
Femasys Shares Are Trading Higher After the Company Announced It Received a U.S Patent for Its Permanent Birth Control Product FemBloc.
Express News | Femasys Announces Issued U.S. Patent Covering Fembloc® Device for Female Permanent Birth Control
H.C. Wainwright Maintains Femasys(FEMY.US) With Buy Rating, Cuts Target Price to $12
Express News | Femasys Announces Partnership With Boston IVF, Prominent Network of Fertility Centers, to Offer Femaseed
Femasys Onboards Infertility Medical Clinic Customers To Offer Its Femaseed Infertility Treatment To Patients In California And Florida.
North Dakota Judge Overturns State's Abortion Ban, Making Abortion Legal In The State
No Data
No Data